Former VP, R&D Asia, and Sr. Research Fellow, Eli Lilly ($106B Market Cap)
CEO， Tyligand Bioscience. Chairman of the BoD of BayHelix Group. 25 years’ experience in new drug discovery and development.
Scientific Advisor and CO-Founder
Professor of Chemistry, Materials Science and NanoEngineering
Department of Chemistry, Rice University
Ranked one of the Top 50 most influential scientists in the world. Over 700 research publications and over 130 patent families. Co-Founder of several companies among them Dotz, Weebit, Universal Matter.
Memorial Sloan Kettering Cancer Center
Head of Cancer Nanomedicine Laboratory
Expert in nanotechnology and cancer and has developed approaches to treat and detect cancer via novel nanotechnology methods. Co-founder of three startup companies.
University of North Carolina, Chapel Hill
Director of Clinical and Translational Research, co-director Urologic Oncology Program
Co-founder of two startup companies for Immunotherapy.
Department of Radiation Oncology, MD Anderson Cancer Center
Expert in radiation-induced immunotherapy. Has developed several approaches for enhancing the effect of immunotherapy through its combination with radiation.
Institut de Radiochirurgie de Paris (Centre Hartmann)
Among the top leading cancer radio-oncologists in Paris. Director and co-founder of the Rafael Institute of Radiochirurgie. His research concerns innovative radio- and chemotherapy for cancer treatment.